MIMS news

Pressurised metered dose inhalers: MHRA warns of cap inhalation risk

Pressurised metered dose inhalers: MHRA warns of cap inhalation risk

Reports of inhaler mouthpiece covers being accidentally...

Prescribing of smoking cessation products plummets after funding cuts

Prescribing of smoking cessation products plummets after funding cuts

The number of primary care prescriptions for nicotine...

One week of steroids 'as effective as two weeks' for severe COPD

One week of steroids 'as effective as two weeks' for severe COPD

A shorter course of steroids lasting 3 to 7 days appears...

Continuous antibiotic prophylaxis prevents recurrent UTIs in patients who self-catheterise

Continuous antibiotic prophylaxis prevents recurrent UTIs in patients who self-catheterise

Continuous low-dose antibiotic prophylaxis is effective...

Top up your e-learning with MIMS Learning's summer school

Top up your e-learning with MIMS Learning's summer school

Ease the run-up to your appraisal with MIMS Learning's...

NICE approves more treatments for MS

NICE approves more treatments for MS

Beta interferons and glatiramer acetate are now options...

New salmeterol/fluticasone inhaler for adult and childhood asthma

New salmeterol/fluticasone inhaler for adult and childhood asthma

The new pressurised metered-dose inhaler (MDI) Combisal...

Prescribing antihypertensive drugs as a single pill 'leads to better outcomes'

Prescribing antihypertensive drugs as a single pill 'leads to better outcomes'

Patients prescribed a combination of antihypertensive...

New MIMS table summarises monitoring requirements for lipid-lowering drugs

New MIMS table summarises monitoring requirements for lipid-lowering drugs

GPs can now use a handy MIMS table to check which tests...

Succeed as a locum with MIMS Learning's key updates

Succeed as a locum with MIMS Learning's key updates

MIMS Learning has launched 4 learning plans worth over...

NICE approves guselkumab for plaque psoriasis

NICE approves guselkumab for plaque psoriasis

Guselkumab (Tremfya) is now an option for routine NHS...

Long-acting anticholinergic licensed for childhood asthma

Long-acting anticholinergic licensed for childhood asthma

Spiriva Respimat (tiotropium) is now licensed for use...

MIMS Respiratory and Allergy Learning workshops 2018 - new Glasgow date announced

MIMS Respiratory and Allergy Learning workshops 2018 - new Glasgow date announced

A free full-day MIMS workshop in Glasgow has just been...

No need to treat most functional gastric disorders in infants

No need to treat most functional gastric disorders in infants

Most functional gastrointestinal problems in infants...

Capsule inhalation warning for tiotropium inhaler

Capsule inhalation warning for tiotropium inhaler

Train patients prescribed Braltus (tiotropium) in the...

PCSK9 inhibitor licensed for risk reduction in established cardiovascular disease

PCSK9 inhibitor licensed for risk reduction in established cardiovascular disease

Repatha (evolocumab) can now be prescribed to reduce...

Cost of low-value prescribing increasing despite fall in items

Cost of low-value prescribing increasing despite fall in items

Despite a fall in prescription numbers for low-value...

Diabetes test strips recalled

Diabetes test strips recalled

Patients with diabetes who use the Accu-Chek Aviva...

Don't miss the chance to register for free clinical education

Don't miss the chance to register for free clinical education

Join over 1400 of your colleagues and a host of expert...

MIMS Respiratory and Allergy Learning workshops 2018 - new Liverpool date announced

MIMS Respiratory and Allergy Learning workshops 2018 - new Liverpool date announced

A free full-day MIMS workshop in Liverpool has just...

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more